{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:06:08Z","timestamp":1778605568929,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jaut.2022.102990","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:43:21Z","timestamp":1672962201000},"page":"102990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features"],"prefix":"10.1016","volume":"135","author":[{"given":"Ch","family":"Lopez-Pedrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Pati\u00f1o-Trives","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Cerd\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ortega-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Sanchez-Pareja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Iba\u00f1ez-Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mu\u00f1oz-Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"\u00c1balos-Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ruiz-Vilchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Segu\u00ed Azpilcueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Barbarroja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Escudero-Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Perez-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2022.102990_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-021-01051-5","article-title":"An update on antiphospholipid syndrome","volume":"23","author":"Xourgia","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2022.102990_bib2","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fimmu.2019.00764","article-title":"New biomarkers for atherothrombosis in antiphospholipid syndrome: genomics and epigenetics approaches","volume":"10","author":"Lopez-Pedrera","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102990_bib3","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"Tsokos","year":"2011","journal-title":"Systemic Lupus Erythematosus. New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.jaut.2022.102990_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera i Segura","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102990_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/rheumatology\/kez239","article-title":"Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?","volume":"59","author":"Pericleous","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2022.102990_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3324\/haematol.2017.184416","article-title":"Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome","volume":"103","author":"P\u00e9rez-S\u00e1nchez","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jaut.2022.102990_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrm3742","article-title":"A day in the life of the spliceosome","volume":"15","author":"Matera","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2022.102990_bib8","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.1073\/pnas.1311839110","article-title":"Differential splicing across immune system lineages","volume":"110","author":"Ergun","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jaut.2022.102990_bib9","first-page":"3284","article-title":"Alternative splicing: a new cause and potential therapeutic target in autoimmune disease","author":"Ren","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102990_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2022.102990_bib11","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"European League against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102990_bib12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2022.102990_bib13","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/ATVBAHA.121.315928","article-title":"Anti-dsDNA antibodies increase the cardiovascular risk in systemic lupus erythematosus promoting a distinctive immune and vascular activation","volume":"41","author":"Pati\u00f1o-Trives","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jaut.2022.102990_bib14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ebiom.2018.10.056","article-title":"Changes in splicing machinery components influence, precede, and early predict the development of type 2 diabetes: from the CORDIOPREV study","volume":"37","author":"Gahete","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaut.2022.102990_bib15","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2019-00021","article-title":"Dysregulation of the splicing machinery is associated to the development of nonalcoholic fatty liver disease","volume":"104","author":"del R\u00edo-Moreno","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2022.102990_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.trsl.2019.07.001","article-title":"Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer","volume":"212","author":"Jim\u00e9nez-Vacas","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.jaut.2022.102990_bib17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/cancers11101439","article-title":"Splicing machinery is dysregulated in pituitary neuroendocrine tumors and is associated with aggressiveness features","volume":"11","author":"V\u00e1zquez-Borrego","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.jaut.2022.102990_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.008","article-title":"Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer","volume":"51","author":"Jim\u00e9nez-Vacas","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaut.2022.102990_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000183","article-title":"Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases","volume":"2","author":"Flint","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2022.102990_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/annrheumdis-2021-220308","article-title":"Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy","volume":"81","author":"Ib\u00e1\u00f1ez-Costa","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102990_bib21","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1128\/MCB.06130-11","article-title":"Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators","volume":"32","author":"Michelle","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2022.102990_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2009.02.127","article-title":"The exon-junction complex proteins, Y14 and MAGOH regulate STAT3 activation","volume":"382","author":"Muromoto","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jaut.2022.102990_bib23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.celrep.2018.09.041","article-title":"RBM17 interacts with U2SURP and CHERP to regulate expression and splicing of RNA-processing proteins","volume":"25","author":"De Maio","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2022.102990_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/cmi.2016.32","article-title":"Sam68 is a regulator of Toll-like receptor signaling","volume":"14","author":"Tomalka","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jaut.2022.102990_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/cas.13452","article-title":"miR\u2010335 inhibited cell proliferation of lung cancer cells by target Tra2\u03b2","volume":"109","author":"Liu","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jaut.2022.102990_bib26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10735-014-9582-3","article-title":"Transformer 2\u03b2 (Tra2\u03b2\/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation","volume":"45","author":"Ji","year":"2014","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.jaut.2022.102990_bib27","first-page":"8665","article-title":"Tra2beta protects against the degeneration of chondrocytes by inhibiting chondrocyte apoptosis via activating the PI3K\/Akt signaling pathway","volume":"24","author":"Zhou","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jaut.2022.102990_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/B978-0-12-394299-9.00006-0","article-title":"An emerging role of RNA-binding proteins as multifunctional regulators of lymphocyte development and function","volume":"115","author":"Turner","year":"2012","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jaut.2022.102990_bib29","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1093\/nar\/gkw041","article-title":"RBM3 regulates temperature sensitive miR-142\u20135p and miR-143 (thermomiRs), which target immune genes and control fever","volume":"44","author":"Wong","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2022.102990_bib30","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1128\/MCB.06327-11","article-title":"Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion","volume":"32","author":"Al-Ayoubi","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2022.102990_bib31","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1128\/MCB.01674-13","article-title":"SRSF10 regulates alternative splicing and is required for adipocyte differentiation","volume":"34","author":"Li","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2022.102990_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004201","article-title":"Plasma cholesterol\u2013induced lesion networks activated before regression of early, mature, and advanced atherosclerosis","volume":"10","author":"Bj\u00f6rkegren","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jaut.2022.102990_bib33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00296-018-4059-4","article-title":"The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease","volume":"38","author":"Dima","year":"2018","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2022.102990_bib34","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s10753-018-0809-4","article-title":"Sam68 promotes invasion, migration, and proliferation of fibroblast-like synoviocytes by enhancing the NF-\u03baB\/P65 pathway in rheumatoid arthritis","volume":"41","author":"Sun","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.jaut.2022.102990_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1073\/pnas.0136770100","article-title":"Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans","volume":"100","author":"Lewis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jaut.2022.102990_bib36","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/art.40585","article-title":"Decreased expression of serine\/arginine\u2010rich splicing factor 1 in T Cells from patients with active systemic lupus erythematosus accounts for reduced expression of RasGRP1 and DNA methyltransferase 1","volume":"70","author":"Kono","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102990_bib37","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/annrheumdis-2013-204600","article-title":"Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus","volume":"74","author":"Perez-Sanchez","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102990_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102990_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/13543784.2019.1551358","article-title":"The Jakinibs in systemic lupus erythematosus: progress and prospects","volume":"28","author":"Mok","year":"2019","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.jaut.2022.102990_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-017-0225-9","article-title":"JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation","volume":"18","author":"Ikeda","year":"2017","journal-title":"BMC Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:29:41Z","timestamp":1760257781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841122001986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":40,"alternative-id":["S0896841122001986"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102990","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102990"}}